Clear Street Group Inc. Takes $30.48 Million Position in Eli Lilly and Company

The investment firm acquired nearly 40,000 shares of the pharmaceutical giant's stock.

Mar. 15, 2026 at 9:51am

Got story updates? Submit your updates here. ›

Clear Street Group Inc. acquired a new stake in Eli Lilly and Company (NYSE:LLY) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 39,950 shares of the company's stock, valued at approximately $30,482,000.

Why it matters

This investment by Clear Street Group Inc. in Eli Lilly and Company, a major pharmaceutical company, signals confidence in the firm's growth potential and product pipeline. Eli Lilly is known for its innovative medicines and therapies, making it an attractive investment for institutional investors like Clear Street Group.

The details

Clear Street Group Inc. purchased 39,950 shares of Eli Lilly and Company stock in the 3rd quarter, valued at around $30.48 million. This represents a new stake for the investment firm in the pharmaceutical giant. Eli Lilly is a global leader in developing and commercializing a broad range of medicines and therapies for patients worldwide.

  • Clear Street Group Inc. acquired the Eli Lilly shares in the 3rd quarter of the year.

The players

Clear Street Group Inc.

An investment firm that acquired a new stake in Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company that researches, develops, manufactures, and commercializes a broad range of medicines and therapies.

Got photos? Submit your photos here. ›

The takeaway

This investment by Clear Street Group Inc. in Eli Lilly and Company highlights the pharmaceutical firm's strong market position and growth potential, as institutional investors seek to capitalize on the company's innovative product pipeline and global reach.